A patient taking 112 µg of Synthroid (levothyroxine) has a thyroid‑stimulating hormone level of 8.47 mIU/L; what dose adjustment is recommended?

Dose Adjustment Recommendation

Increase the Synthroid dose by 25 µg to 137 µg daily (or alternatively to 125 µg if 137 µg is not available), and recheck TSH in 6-8 weeks.

Rationale for Dose Increase

This patient has a TSH of 8.47 mIU/L while on 112 µg of levothyroxine, indicating inadequate replacement therapy. The TSH is elevated above the normal reference range (typically 0.4-4.5 mIU/L), meaning the current dose is insufficient to achieve euthyroidism 1.

The levothyroxine dose should be adjusted to bring the serum TSH into the reference range 1. For patients already on levothyroxine therapy with elevated TSH, guidelines recommend incremental dose adjustments of 12.5-25 µg daily until the TSH normalizes 2.

Specific Dosing Strategy

• Standard increment: Increase by 12.5-25 µg 2
• For this patient on 112 µg with TSH of 8.47 mIU/L, a 25 µg increase to 137 µg (or 125 µg if 137 µg tablets unavailable) is appropriate
• Recheck TSH in 6-8 weeks after the dose adjustment 2, 3

The FDA label confirms that dose adjustments are guided by serum TSH determinations 4-8 weeks following dosage adjustments, and that levothyroxine sodium doses are generally adjusted in 12.5-25 µg increments until the patient is clinically euthyroid and serum TSH has normalized 3.

Important Considerations Before Adjusting

Rule Out Non-Compliance and Malabsorption First

Before increasing the dose, verify medication adherence and proper administration 2, 3:

• Timing: Levothyroxine must be taken on an empty stomach, 30-60 minutes before breakfast with water only 2
• Interfering substances: Ensure the patient is not taking medications or supplements within 4 hours that interfere with absorption, including:
  • Iron supplements
  • Calcium supplements
  • Antacids
  • Proton pump inhibitors (though short-term studies show minimal impact)
  • Soy products 2, 3

Non-compliance is the most common cause of persistently elevated TSH in patients on high doses (>200 µg/day) 2. However, at 112 µg, this patient is not yet on a high dose, making true under-replacement more likely than non-compliance.

Confirm the Elevated TSH

If this is the first elevated TSH reading, consider repeating the TSH in 2 months before adjusting, as 62% of elevated TSH levels may spontaneously normalize 4. However, if the patient is symptomatic or this represents a confirmed pattern, proceed with dose adjustment.

Monitoring After Adjustment

• Recheck TSH in 6-8 weeks after any dose change 2, 3
• The goal is to achieve a TSH in the normal reference range (typically 0.4-4.5 mIU/L) 1, 2
• Some patients may feel better with TSH in the lower half of the reference range, particularly if they remain symptomatic despite TSH in the upper normal range 1
• Once stable, monitor TSH every 6-12 months 2

Special Populations Requiring Caution

If this patient is over age 50-60 or has cardiac disease, smaller increments (12.5 µg) with slower titration may be safer 2, 3. However, the standard 25 µg increment is generally well-tolerated in younger patients without cardiac disease 2, 3.

Common Pitfalls to Avoid

• Do not over-adjust: Avoid increasing by more than 25 µg at a time, as this risks overtreatment with cardiovascular and skeletal consequences 2, 3
• Do not wait too long: TSH levels may take 8 weeks or longer to plateau after small dose adjustments, but 6-8 weeks is the standard reassessment interval 2
• Do not ignore symptoms: If the patient remains symptomatic despite normalized TSH, consider targeting the lower half of the reference range 1